BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18194821)

  • 1. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
    Zambruni A; Trevisani F; Di Micoli A; Savelli F; Berzigotti A; Bracci E; Caraceni P; Domenicali M; Felline P; Zoli M; Bernardi M
    J Hepatol; 2008 Mar; 48(3):415-21. PubMed ID: 18194821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval correction in patients with cirrhosis.
    Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
    J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hydrophilic and lipophilic beta-blockers on heart rate, ventricular repolarization and their interrelationship in normal subjects.
    Iacoviello M; Massari F; De Laura D; Guida P; Mastropasqua F; Forleo C; Rizzon P; Pitzalis MV
    Ital Heart J; 2000 May; 1(5):331-5. PubMed ID: 10832808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval analysis in patients with chronic liver disease: a prospective study.
    Kosar F; Ates F; Sahin I; Karincaoglu M; Yildirim B
    Angiology; 2007; 58(2):218-24. PubMed ID: 17495272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
    Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
    Vorobioff JD; Ferretti SE; Zangroniz P; Gamen M; Picabea E; Bessone FO; Reggiardo V; Diez AR; Tanno M; Cuesta C; Tanno HE
    Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cisapride does not modify prolonged Q-T interval in patients with liver cirrhosis].
    Quera R; Madrid AM; Ugalde H; Defilippi C
    Rev Med Chil; 2000 Aug; 128(8):847-52. PubMed ID: 11129545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation.
    Kim YK; Hwang GS; Shin WJ; Bang JY; Cho SK; Han SM
    Transplant Proc; 2011 Jun; 43(5):1654-9. PubMed ID: 21693252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
    González A; Augustin S; Pérez M; Dot J; Saperas E; Tomasello A; Segarra A; Armengol JR; Malagelada JR; Esteban R; Guardia J; Genescà J
    Hepatology; 2006 Oct; 44(4):806-12. PubMed ID: 17006916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors.
    Bernardi M; Calandra S; Colantoni A; Trevisani F; Raimondo ML; Sica G; Schepis F; Mandini M; Simoni P; Contin M; Raimondo G
    Hepatology; 1998 Jan; 27(1):28-34. PubMed ID: 9425913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical investigation of Q-T prolongation in hepatic cirrhosis].
    Li L; Liu HR; Shu JL; Xi XP; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2717-8. PubMed ID: 18167253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate.
    Henriksen JH; Gülberg V; Fuglsang S; Schifter S; Bendtsen F; Gerbes AL; Møller S
    Scand J Clin Lab Invest; 2007; 67(6):643-53. PubMed ID: 17852825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.